Next Article in Journal
Calcidiol Deficiency in End-Stage Organ Failure and after Solid Organ Transplantation: Status quo
Next Article in Special Issue
Influence of microRNA on the Maintenance of Human Iron Metabolism
Previous Article in Journal
Modulation of Immune Function by Polyphenols: Possible Contribution of Epigenetic Factors
Previous Article in Special Issue
Multi-Copper Oxidases and Human Iron Metabolism
Article Menu

Export Article

Open AccessReview
Nutrients 2013, 5(7), 2333-2351;

Intestinal Iron Homeostasis and Colon Tumorigenesis

Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA
Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109, USA
Author to whom correspondence should be addressed.
Received: 3 May 2013 / Revised: 29 May 2013 / Accepted: 7 June 2013 / Published: 28 June 2013
(This article belongs to the Special Issue Dietary Iron and Human Health)
Full-Text   |   PDF [551 KB, uploaded 28 June 2013]   |  


Colorectal cancer (CRC) is the third most common cause of cancer-related deaths in industrialized countries. Understanding the mechanisms of growth and progression of CRC is essential to improve treatment. Iron is an essential nutrient for cell growth. Iron overload caused by hereditary mutations or excess dietary iron uptake has been identified as a risk factor for CRC. Intestinal iron is tightly controlled by iron transporters that are responsible for iron uptake, distribution, and export. Dysregulation of intestinal iron transporters are observed in CRC and lead to iron accumulation in tumors. Intratumoral iron results in oxidative stress, lipid peroxidation, protein modification and DNA damage with consequent promotion of oncogene activation. In addition, excess iron in intestinal tumors may lead to increase in tumor-elicited inflammation and tumor growth. Limiting intratumoral iron through specifically chelating excess intestinal iron or modulating activities of iron transporter may be an attractive therapeutic target for CRC. View Full-Text
Keywords: iron; colorectal cancer; divalent metal transporter-1 (DMT-1); hepcidin; HIF; ferroportin (FPN) iron; colorectal cancer; divalent metal transporter-1 (DMT-1); hepcidin; HIF; ferroportin (FPN)

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Xue, X.; Shah, Y.M. Intestinal Iron Homeostasis and Colon Tumorigenesis. Nutrients 2013, 5, 2333-2351.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top